Mindoula Health Announces Launch of Alzheimer Patient Caregiver Study
Published in News,
Leading behavioral health company partners with AnthroTronix for Health-eBrain Study II
July 26, 2016 – SILVER SPRING, Md. – Mindoula Health, a technology-enabled case management company at the forefront of the transformation of behavioral healthcare, has announced the launch of the HealtheBrain Study II with partner AnthroTronix, the developer of the FDA-cleared brain health assessment mobile app, DANA™. Funded by BrightFocus Foundation and the Geoffrey Beene Foundation Alzheimer’s Initiative, the Health-eBrain Study II holds out hope for caregivers of the estimated 87% of Alzheimer’s patients who are cared for in the home setting by family members and friends.
Mindoula will deploy its virtual case management team and proprietary multiplatform technology to provide 24/7 virtual support to Alzheimer’s caregivers with symptoms of depression, and help them monitor their brain health with DANA™. Participation in the study is free for caregivers but space is limited. Caregivers interested in participating can visit the Health-eBrain website to qualify: https://www.health-ebrainstudy.org.
AnthroTronix, an engineering research and development company, produces human-centered technologies that advance health, communication, education, and defense. It develops innovative, research-based technologies that influence change and enhance lives around the world. AnthroTronix has been recognized among Inc. Magazine’s “5000 Fastest Growing Companies” and selected by the World Economic Forum as a Technology Pioneer company.
“In Health-eBrain Study I, we found that dementia caregivers had decreased cognitive performance compared with matched controls,” said Dr. Cori Lathan, Founder & CEO of AnthroTronix. “So this next phase has two ambitious simultaneous goals – to look at caregiver stressors that could be possible causes for this decreased cognitive performance as well as provide an intervention that could help these caregivers with their mental health. When we found Mindoula’s technology-enabled case management solution, we immediately recognized the potential to help caregivers deal with the stress and burden of caregiving, and are thrilled to be Mindoula’s partner in Health-eBrain Study II.”
“We’re honored that AnthroTronix saw the power of our intervention combined with its FDA-cleared mobile cognitive assessment app,” said Steve Sidel, Founder & CEO of Mindoula. “Our virtual solution will provide around-the-clock support to caregivers, with easy-to-use features like secure texting and check-ins, telephonic support, app-based monitoring, and assessments such as the M3 Checklist. The Health-eBrain Study II would not have been possible without the research grant provided by the BrightFocus Foundation and the Geoffrey Been Foundation Alzheimer’s Initiative, and we are grateful for their generous financial support.”
BrightFocus is one of America’s leading supporters of basic scientific investigations to better understand and find cures for Alzheimer’s disease, age-related macular degeneration, and glaucoma. Since 1973, it has awarded more than $163 million to scientists seeking new approaches to prevention, diagnosis, and treatment of its target diseases, including the inventors of the first artificial heart and two Nobel prize winners.
“We call ourselves BrightFocus because we want to end these diseases and shine a light on them,” said Stacy Pagos Haller, President and CEO, BrightFocus Foundation. “The researchers we fund are our rock stars. There are the people who are in the trenches changing lives forever.”
The Geoffrey Beene Foundation Alzheimer’s Initiative, underwritten by the Geoffrey Beene Foundation, is a leading supporter of innovative new projects that advance awareness, diagnoses and research in early stages of Alzheimer’s disease, and also collaborates with inventor/entrepreneurs and researchers on realworld systems and tools that accelerate the study of Alzheimer’s and engage the public as Citizen Scientists. Mery Comer, its President and CEO, is the New York Times bestselling author of Slow Dancing with a Stranger, and is also co-founder of Women Against Alzheimer’s, and the recipient of the 2014 Wertheim Global Medical Leadership Award, 2007 Proxmire Award, and 2005 Shriver Profiles in Dignity Award.
“Caregivers are the ‘second victim’ of long-term chronic diseases like Alzheimer’s and other neurodegenerative diseases because of the intensity of care over years that jeopardizes their own health,” said Ms. Comer. “That’s why studies like the Health-eBrain Study II that test real world interventions to care for the caregivers are so important. We are rooting for the success of Mindoula and AnthroTronix in this study so that an innovative, real-world intervention like this one can be brought to market with all deliberate haste.”
Mindoula Health is a technology-enabled case management company headquartered in Silver Spring, Maryland, that provides 24/7 virtual and in-person support to individuals and families facing behavioral health challenges. Its proprietary telehealth platform which includes a HIPAA compliant mobile engagement app, proprietary psychometrics, predictive analytics, and collaborative care software, enables its team of case managers and peer support specialists to deliver market leading behavioral health outcome improvements and reduce healthcare costs. A leader in the areas of case management, collaborative care, and behavioral health population management, Mindoula is at the forefront of the transformation of behavioral healthcare.
Kristi Stovall, Marketing & Public Relations